Combined biparametric prostate magnetic resonance imaging and prostate-specific antigen in the detection of prostate cancer: A validation study in a biopsy-naive patient population

Urology

Volumn 88, Issue , 2016, Pages 125-134

  Fascelli, Michele ^a   Rais Bahrami, Soroush ^a,c   Sankineni, Sandeep ^a   Brown, Anna M ^a   George, Arvin K ^a   Ho, Richard ^a   Frye, Thomas ^a   Kilchevsky, Amichai ^a   Chelluri, Raju ^a   Abboud, Steven ^a   Minhaj Siddiqui, M ^a,d   Merino, Maria J ^a   Wood, Bradford J ^b   Choyke, Peter L ^a   Pinto, Peter A ^a,b   Turkbey, Baris ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIPARAMETRIC PROSTATE MAGNETIC RESONANCE IMAGING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; VALIDATION STUDY; AGED; BIOPSY; BLOOD; MIDDLE AGED; PROCEDURES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84960127312     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.09.035     Document Type: Article

References (23)

1. J.A. Cohn, Wang C.E., J.C. Lakeman, and et al. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation Urol Oncol 32 2014 41 e23-41.e30
2. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J Clin 65 2015 5 29
3. M.M. Siddiqui, S. Rais-Bahrami, B. Turkbey, and et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer JAMA 313 2015 390 397
4. A.K. George, P.A. Pinto, and S. Rais-Bahrami Multiparametric MRI in the PSA Screening Era Biomed Res Int 2014 10.1155/2014/465816
5. S. Rais-Bahrami, M.M. Siddiqui, B. Turkbey, and et al. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer J Urol 190 2013 1721 1727
6. B. Turkbey, H. Mani, V. Shah, and et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds J Urol 186 2011 1818 1824
7. J.D. Le, S. Stephenson, M. Brugger, and et al. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology J Urol 192 2014 1367 1373
8. A.R. Rastinehad, B. Turkbey, S.S. Salami, and et al. Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy J Urol 191 2014 1749 1754
9. A. Walton Diaz, N.A. Shakir, A.K. George, and et al. Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance Urol Oncol 33 2015 202 e1-7
10. D. Raskolnikov, A.K. George, S. Rais-Bahrami, and et al. Multiparametric magnetic resonance imaging and image-guided biopsy to detect seminal vesicle invasion by prostate cancer J Endourol 28 2014 1283 1289
11. D. Raskolnikov, A.K. George, S. Rais-Bahrami, and et al. The role of magnetic resonance image-guided prostate biopsy in stratifying men for risk of extracapsular extension at radical prostatectomy J Urol 194 2015 105 111
12. S. Rais-Bahrami, M.M. Siddiqui, S. Vourganti, and et al. Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies BJU Int 115 2015 381 388
13. P.A. Pinto, P.H. Chung, A.R. Rastinehad, and et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging J Urol 186 2011 1281 1285
14. Hong C.W., S. Rais-Bahrami, A. Walton-Diaz, and et al. Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approaches BJU Int 115 2015 772 779
15. B. Turkbey, H. Mani, O. Aras, and et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268 2013 144 152
16. M. Abd-Alazeez, A. Kirkham, H.U. Ahmed, and et al. Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard Prostate Cancer Prostatic Dis 17 2014 40 46
17. A. Peltier, F. Aoun, M. Lemort, F. Kwizera, M. Paesmans, and R. Van Velthoven MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men Biomed Res Int 2015 10.1155/2015/571708
18. M. Quentin, D. Blondin, C. Arsov, and et al. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen J Urol 192 2014 1374 1379
19. J.K. Logan, S. Rais-Bahrami, B. Turkbey, and et al. Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies BJU Int 114 2014 641 652
20. S. Fakhran, L. Alhilali, H. Kale, and E. Kanal Assessment of rates of acute adverse reactions to gadobenate dimeglumine: review of more than 130,000 administrations in 7.5 years AJR Am J Roentgenol 204 2015 703 706
21. S. Aran, K.W. Shaqdan, and H.H. Abujudeh Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194,400 injections Clin Radiol 70 2015 466 476
22. B. Turkbey, V.P. Shah, Pang Y., and et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258 2011 488 495
23. F. De Cobelli, S. Ravelli, A. Esposito, and et al. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen AJR Am J Roentgenol 204 2015 550 557